Literature DB >> 10698588

Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).

Z Laron1.   

Abstract

A description of the clinical, biochemical and endocrinological features of the classical form of the syndrome of primary growth hormone (GH) resistance (Laron syndrome) is presented including the progressive changes during follow-up from infancy into adulthood. The main diagnostic features are: severe growth retardation, acromicria, small gonads and genitalia, and obesity. Serum GH levels are elevated and insulin-like growth factor-I (IGF-I) values are low and do not rise upon stimulation by exogenous hGH. The pathogenesis of this syndrome is due to various molecular defects from exon deletion to nonsense, frameshift, splice and missense mutations in the GH receptor (GH-R) gene or in its post-receptor pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698588

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  15 in total

Review 1.  Regulation of Skeletal Homeostasis.

Authors:  Mone Zaidi; Tony Yuen; Li Sun; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 2.  Growth hormone insensitivity: diagnostic and therapeutic approaches.

Authors:  S Kurtoğlu; N Hatipoglu
Journal:  J Endocrinol Invest       Date:  2015-06-11       Impact factor: 4.256

3.  Laron syndrome abnormalities: spinal stenosis, os odontoideum, degenerative changes of the atlanto-odontoid joint, and small oropharynx.

Authors:  Liora Kornreich; Gadi Horev; Michael Schwarz; Boaz Karmazyn; Zvi Laron
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

Review 4.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

5.  Identification of two novel mutations in the human growth hormone receptor gene.

Authors:  O Shevah; P Borrelli; M Rubinstein; Z Laron
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

6.  Relationship between initial treatment effect of recombinant human growth hormone and exon 3 polymorphism of growth hormone receptor in Chinese children with growth hormone deficiency.

Authors:  Zhangqian Zheng; Lingfeng Cao; Zhou Pei; Dijing Zhi; Zhuhui Zhao; Li Xi; Ruoqian Cheng; Feihong Luo
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 7.  Genomic dissection of the cytokine-controlled STAT5 signaling network in liver.

Authors:  Atsushi Hosui; Lothar Hennighausen
Journal:  Physiol Genomics       Date:  2008-05-06       Impact factor: 3.107

8.  Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.

Authors:  Danilo Fintini; Claudia Brufani; Marco Cappa
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

Review 9.  Laron syndrome - A historical perspective.

Authors:  Zvi Laron; Haim Werner
Journal:  Rev Endocr Metab Disord       Date:  2020-09-22       Impact factor: 6.514

Review 10.  Genetic causes of growth hormone insensitivity beyond GHR.

Authors:  Vivian Hwa; Masanobu Fujimoto; Gaohui Zhu; Wen Gao; Corinne Foley; Meenasri Kumbaji; Ron G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2020-10-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.